Dr. Sasine on Predicting Individual Benefit with CAR T Cells
Joshua P. Sasine, MD, PhD, discusses the challenges in predicting a patient’s individual benefit with CAR T-cell therapy in hematologic malignancies.
Dr. Sasine on New Developments With CAR T-Cell Therapy
Joshua P. Sasine, MD, PhD, clinical instructor of medicine, hematologist, and oncologist, University of California, Los Angeles, discusses new developments with CAR T-cell therapy.
Dr. Sasine on Determining Outlook With CAR T-Cell Therapy in Hematologic Cancers
Joshua P. Sasine, MD, PhD, clinical instructor of medicine, University of California, Los Angeles, discusses how to determine if a patient will have a response to CAR T-cell therapy.